These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 7434310)

  • 1. Cryptogenic fibrosing alveolitis and lung cancer.
    Turner-Warwick M; Lebowitz M; Burrows B; Johnson A
    Thorax; 1980 Jul; 35(7):496-9. PubMed ID: 7434310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung cancer and cryptogenic fibrosing alveolitis. A population-based cohort study.
    Hubbard R; Venn A; Lewis S; Britton J
    Am J Respir Crit Care Med; 2000 Jan; 161(1):5-8. PubMed ID: 10619790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibrosing alveolitis associated with systemic sclerosis has a better prognosis than lone cryptogenic fibrosing alveolitis.
    Wells AU; Cullinan P; Hansell DM; Rubens MB; Black CM; Newman-Taylor AJ; Du Bois RM
    Am J Respir Crit Care Med; 1994 Jun; 149(6):1583-90. PubMed ID: 8004317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cryptogenic fibrosing alveolitis and lung cancer: the BTS study.
    Harris JM; Johnston ID; Rudd R; Taylor AJ; Cullinan P
    Thorax; 2010 Jan; 65(1):70-6. PubMed ID: 19996344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cryptogenic fibrosing alveolitis with preserved lung volumes.
    Doherty MJ; Pearson MG; O'Grady EA; Pellegrini V; Calverley PM
    Thorax; 1997 Nov; 52(11):998-1002. PubMed ID: 9487350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional impairment in lone cryptogenic fibrosing alveolitis and fibrosing alveolitis associated with systemic sclerosis: a comparison.
    Wells AU; Hansell DM; Rubens MB; Cailes JB; Black CM; du Bois RM
    Am J Respir Crit Care Med; 1997 May; 155(5):1657-64. PubMed ID: 9154872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. British Thoracic Society study of cryptogenic fibrosing alveolitis: current presentation and initial management. Fibrosing Alveolitis Subcommittee of the Research Committee of the British Thoracic Society.
    Johnston ID; Prescott RJ; Chalmers JC; Rudd RM
    Thorax; 1997 Jan; 52(1):38-44. PubMed ID: 9039238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bronchoalveolar lavage cellularity: lone cryptogenic fibrosing alveolitis compared with the fibrosing alveolitis of systemic sclerosis.
    Wells AU; Hansell DM; Haslam PL; Rubens MB; Cailes J; Black CM; du Bois RM
    Am J Respir Crit Care Med; 1998 May; 157(5 Pt 1):1474-82. PubMed ID: 9603126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cryptogenic fibrosing alveolitis and the fibrosing alveolitis of systemic sclerosis: morphological differences on computed tomographic scans.
    Chan TY; Hansell DM; Rubens MB; du Bois RM; Wells AU
    Thorax; 1997 Mar; 52(3):265-70. PubMed ID: 9093344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lone cryptogenic fibrosing alveolitis: a functional-morphologic correlation based on extent of disease on thin-section computed tomography.
    Wells AU; King AD; Rubens MB; Cramer D; du Bois RM; Hansell DM
    Am J Respir Crit Care Med; 1997 Apr; 155(4):1367-75. PubMed ID: 9105081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial cryptogenic fibrosing alveolitis: a case report.
    Stinson JC; Tomkin GH
    Ir J Med Sci; 1992 Feb; 161(2):42-3. PubMed ID: 1517052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival in patients with cryptogenic fibrosing alveolitis: a population-based cohort study.
    Hubbard R; Johnston I; Britton J
    Chest; 1998 Feb; 113(2):396-400. PubMed ID: 9498958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rising mortality from cryptogenic fibrosing alveolitis.
    Johnston I; Britton J; Kinnear W; Logan R
    BMJ; 1990 Nov; 301(6759):1017-21. PubMed ID: 2249048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High resolution computed tomographic assessment of asbestosis and cryptogenic fibrosing alveolitis: a comparative study.
    al-Jarad N; Strickland B; Pearson MC; Rubens MB; Rudd RM
    Thorax; 1992 Aug; 47(8):645-50. PubMed ID: 1412123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exposure to commonly prescribed drugs and the etiology of cryptogenic fibrosing alveolitis: a case-control study.
    Hubbard R; Venn A; Smith C; Cooper M; Johnston I; Britton J
    Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):743-7. PubMed ID: 9517585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma lactate dehydrogenase: a marker of disease activity in cryptogenic fibrosing alveolitis and extrinsic allergic alveolitis?
    Matusiewicz SP; Williamson IJ; Sime PJ; Brown PH; Wenham PR; Crompton GK; Greening AP
    Eur Respir J; 1993 Oct; 6(9):1282-6. PubMed ID: 8287944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bronchoalveolar lavage fluid cell counts in cryptogenic fibrosing alveolitis and their relation to therapy.
    Haslam PL; Turton CW; Lukoszek A; Salsbury AJ; Dewar A; Collins JV; Turner-Warwick M
    Thorax; 1980 May; 35(5):328-39. PubMed ID: 7434282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cryptogenic fibrosing alveolitis and carcinoma of the lung.
    Shankar PS
    Indian J Med Sci; 1983 Apr; 37(4):68-70. PubMed ID: 6618552
    [No Abstract]   [Full Text] [Related]  

  • 19. Capsaicin induced cough in cryptogenic fibrosing alveolitis.
    Doherty MJ; Mister R; Pearson MG; Calverley PM
    Thorax; 2000 Dec; 55(12):1028-32. PubMed ID: 11083888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating antibodies to lung protein(s) in patients with cryptogenic fibrosing alveolitis.
    Wallace WA; Roberts SN; Caldwell H; Thornton E; Greening AP; Lamb D; Howie SE
    Thorax; 1994 Mar; 49(3):218-24. PubMed ID: 8202877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.